Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
about
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathwayUXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.Lysyl Oxidase and the Tumor MicroenvironmentThe potential for targeting extracellular LOX proteins in human malignancy.Lysyl oxidase in cancer research.Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorLysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity
P2860
Q28816968-D8C1150A-A078-4DED-A983-5127C96425CCQ33292171-C22611FE-2A3D-416B-8EB1-301BB84740F7Q37631469-DF3F7291-A045-48EA-B7D5-E1F3D399B372Q38172108-D5DBF95E-DE93-4E89-8D34-C79238733F47Q38241992-20DA1289-132A-4B1B-BEB1-D562B3BBED65Q38243878-4B798C30-0841-493C-9EFD-1961902DB8AEQ38563638-D004CF66-559D-4E05-BF1F-62299BCEF5CBQ38723997-A0C5F9A8-BD09-486F-9679-DDBD5F8A52DEQ38989588-9624364D-DCE3-4C9D-B5BF-55EEEBE79B55Q39634845-7A6870B9-48CB-4966-87DD-A19542B7928AQ40068242-E5994A7C-15ED-4268-86F5-4F492943FCCFQ40251892-3295D8D4-20AC-4A80-89BF-AA9E92B9BD7CQ41224633-DD02F6A4-73B9-48D4-8053-949AA6AC3FE5Q41243739-F38BD5DB-F0F1-4322-AEA9-20530D7AFFCBQ41739827-901C7C47-2081-431A-B3FC-EB8F6C221CEEQ58763545-847337FB-E541-4FD6-A4C8-A1BECCC4B197
P2860
Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@ast
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@en
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@nl
type
label
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@ast
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@en
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@nl
prefLabel
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@ast
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@en
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@nl
P2093
P2860
P1433
P1476
Lysyl oxidase is downregulated ...... vities in Ewing sarcoma cells.
@en
P2093
Florencia Cidre
Javier Alonso
Juan de la Parra
Laura García-García
Noelia Agra
P2860
P304
P356
10.1371/JOURNAL.PONE.0066281
P407
P577
2013-06-04T00:00:00Z